Vivo Bio Tech (BOM:511509) FCF Margin %: 0.00% (As of Mar. 2026)


BOM:511509 Vivo Bio Tech Ltd BOM:511509
68 GF Score
Price ₹23.04
GF Value ₹29.55
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Vivo Bio Tech FCF Margin %?

Vivo Bio Tech BOM:511509 -1.41% 68 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates BOM:511509 with a GF Score™ of 68/100 and a GF Value™ of ₹29.55 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 958 Biotechnology companies, Vivo Bio Tech ranks better than 71.4% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vivo Bio Tech's Free Cash Flow for the three months ended in Mar. 2026 was ₹0.0 Mil. Vivo Bio Tech's Revenue for the three months ended in Mar. 2026 was ₹142.0 Mil. Therefore, Vivo Bio Tech's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Vivo Bio Tech's current FCF Yield % is -4.90%.

The historical rank and industry rank for Vivo Bio Tech's FCF Margin % or its related term are showing as below:

BOM:511509' s FCF Margin % Range Over the Past 10 Years
Min: -67.07   Med: -6.21   Max: 20.75
Current: -4.7

During the past 13 years, the highest FCF Margin % of Vivo Bio Tech was 20.75%. The lowest was -67.07%. And the median was -6.21%.

BOM:511509's FCF Margin % is ranked better than
71.4% of 958 companies
in the Biotechnology industry
Industry Median: -85.21 vs BOM:511509: -4.70

Vivo Bio Tech FCF Margin % Related Terms

Vivo Bio Tech FCF Margin % Historical Data

* Premium members only.

The historical data trend for Vivo Bio Tech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivo Bio Tech FCF Margin % Chart

Vivo Bio Tech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -67.07 20.75 16.66 -22.37 -4.70

Vivo Bio Tech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOM:511509 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Vivo Bio Tech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vivo Bio Tech FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vivo Bio Tech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vivo Bio Tech's FCF Margin % falls into.


BOM:511509
68GF Score
Vivo Bio Tech Ltd BOM:511509
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivo Bio Tech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vivo Bio Tech's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-25.067/533.347
=-4.70 %

Vivo Bio Tech's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/142.011
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Vivo Bio Tech (BOM:511509) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vivo Bio Tech and its competitors. According to the industry distribution chart, Vivo Bio Tech ranks #274 out of 958 companies in the Biotechnology industry, placing it in the top 28.6%.
Is Vivo Bio Tech's FCF Margin % too high?
Vivo Bio Tech's current FCF Margin % is 0.00%. Based on the distribution chart, Vivo Bio Tech ranks #274 out of 958 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Vivo Bio Tech has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vivo Bio Tech's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Vivo Bio Tech ranks #274 out of 958 companies for FCF Margin %. This puts Vivo Bio Tech in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vivo Bio Tech and its competitors. Vivo Bio Tech's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivo Bio Tech stock overvalued right now?
Based on GuruFocus' analysis, Vivo Bio Tech (BOM:511509) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹29.55, compared to a current price of ₹23.04 — trading 22% below its estimated fair value. The current FCF Margin % is 0.00%. Vivo Bio Tech's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Vivo Bio Tech (BOM:511509), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vivo Bio Tech (BOM:511509) Overvalued in 2026?

Based on GuruFocus' analysis, Vivo Bio Tech stock appears to be undervalued. The current stock price of ₹23.04 is trading 22% below its estimated GF Value™ of ₹29.55. GuruFocus considers Vivo Bio Tech to be Modestly Undervalued.

Key valuation signals for BOM:511509:

  • FCF Margin %: 0.00%
  • GF Value™: ₹29.55 vs. price of ₹23.04 (22% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the BOM:511509 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vivo Bio Tech Business Description

Address Number 8-2-672/ 5 & 6, Road Number 1, 3rd Floor, Ilyas Mohammed Khan Estate, Banjara hills, Hyderabad, TG, IND, 500034
Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.
68GF Score

Get the complete analysis for BOM:511509

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹23.04
Price
₹29.55
GF Value